perinat
death
pd
devast
obstetr
complic
determin
caus
death
help
understand
occur
indispens
aid
parent
want
understand
babi
die
determin
recurr
risk
manag
subsequ
pregnanc
consequ
perinat
death
requir
adequ
diagnost
investig
import
first
step
analysi
pd
identifi
case
circumst
includ
relev
detail
regard
matern
histori
obstetr
histori
current
pregnanc
complic
evalu
record
next
step
placent
examin
suggest
case
togeth
molecular
cytogenet
evalu
fetal
autopsi
investig
fetalematern
hemorrhag
kleihauer
also
recommend
standard
case
parent
consent
autopsi
altern
approach
minim
invas
postmortem
examin
postmortem
magnet
reson
imag
fetal
photograph
good
altern
investig
perform
import
combin
find
clinic
review
investig
togeth
identifi
probabl
caus
death
counsel
parent
regard
loss
perinat
death
pd
includ
stillbirth
sb
neonat
death
seven
day
birth
devast
obstetr
complic
global
health
problem
determin
pathophysiolog
pathway
eventu
result
perinat
death
help
understand
occur
aid
parent
mourn
process
valu
determin
recurr
risk
necessarili
counsel
manag
futur
pregnanc
provid
better
insight
underli
patholog
mechan
contribut
risk
factor
help
develop
intervent
strategi
determin
caus
death
adequ
diagnost
investig
need
import
differ
exist
wellinvestig
audit
unexplain
perinat
death
unexplain
caus
perinat
death
evalu
therefor
classifi
unexplain
evalu
pd
especi
stillbirth
protocol
underus
often
knowledg
regard
epidemiolog
risk
factor
valuabl
diagnost
test
lack
mani
hospit
local
protocol
evalu
sb
absent
search
past
year
literatur
evidencebas
investig
pd
aim
review
exist
opinion
evalu
pd
review
literatur
focu
mainli
sb
investig
inform
current
practic
relat
investig
neonat
death
limit
therefor
articl
focus
investig
sb
case
neonat
death
clinic
scenario
result
death
obviou
investig
mostli
guid
clinic
condit
case
complic
pregnanc
labor
follow
neonat
death
opinion
investig
sb
applic
also
includ
placent
investig
underli
caus
first
event
chain
event
result
death
often
similar
import
first
step
diagnost
workup
sb
care
evalu
circumst
sb
relat
particular
clinic
scenario
exampl
question
ask
determin
exactli
fetal
death
identifi
matern
clinic
condit
circumst
death
occur
mother
fetu
placenta
suffer
relev
medic
condit
complic
sever
risk
factor
associ
pd
matern
obes
smoke
previou
stillbirth
box
list
relev
detail
regard
matern
medic
histori
obstetr
histori
current
pregnanc
complic
drug
medic
risk
factor
associ
pd
therefor
evalu
record
matern
diseas
associ
higher
risk
perinat
death
box
howev
analysi
caus
death
one
focu
matern
diseas
often
relat
caus
stillbirth
case
perinat
mortal
routin
investig
matern
diseas
thyroid
dy
function
diabet
without
clinic
featur
recommend
exampl
seem
unlik
sb
could
caus
undiagnos
mild
glucos
intoler
subclin
thyroid
diseas
addit
test
matern
diseas
guid
matern
medic
histori
relev
matern
fetal
clinic
condit
determin
clinic
examin
inherit
thrombophilia
describ
risk
factor
sb
may
result
either
impair
implant
placent
placent
thrombosi
placent
insuffici
infarct
abrupt
publish
literatur
regard
preval
inherit
andor
acquir
thrombophilia
women
sb
without
histori
deep
venou
thromboembol
posit
famili
histori
inherit
thrombophilia
conflict
two
small
cohort
women
sb
increas
preval
prothrombin
mutat
factor
ii
report
antithrombin
activ
factor
v
leiden
protein
cs
defici
acquir
thrombophilia
preval
similar
group
without
fetal
mortal
anoth
cohort
women
fetal
death
women
test
posit
least
one
thrombophilia
preval
even
higher
placent
patholog
identifi
caus
fetal
death
anoth
studi
concern
women
sb
factor
v
leiden
mutat
associ
otherwis
unexplain
caus
fetal
death
odd
ratio
confid
interv
ci
sb
placent
abrupt
infarct
ci
contrast
find
increas
risk
inherit
thrombophilia
report
analysi
two
larg
cohort
women
sb
group
coupl
sb
preval
inherit
trombophilia
includ
factor
v
leiden
prothrombin
mutat
lupu
anticoagul
higher
gener
popul
although
preval
thrombophil
defect
higher
compar
gener
popul
sb
caus
placent
abrupt
infarct
anoth
cohort
matern
fetalplacent
thrombophilia
analyz
almost
women
sb
compar
cohort
mother
live
birth
matern
factor
v
leiden
weakli
associ
sb
vs
ci
wherea
matern
fetal
placent
thrombophilia
includ
prothrombin
mutat
conclus
routin
test
inherit
thrombophilia
part
evalu
sb
support
unless
patholog
confirm
abrupt
sever
infarct
thrombosi
caus
fetal
death
screen
thrombophilia
may
consid
women
histori
venou
thromboembol
famili
histori
hereditari
trombophilia
prevent
matern
thromboembol
futur
antiphospholipid
antibodi
includ
lupu
anticoagul
anticardiolipin
antiprothrombin
associ
sb
antibodi
contribut
placent
insuffici
abnorm
placent
develop
placent
damag
caus
inflamm
thrombosi
infarct
cohort
women
stillborn
babi
elev
level
anticardiolipin
antibodi
found
compar
women
live
birth
preval
even
higher
group
women
unexplain
sb
howev
antiphospholipid
antibodi
also
found
mother
healthi
live
birth
cohort
women
sb
test
posit
lupu
anticoagul
andor
anticardiolipin
antibodi
suggest
antiphospholipid
syndrom
ap
seri
sb
suggest
ap
underli
caus
death
classifi
accord
tulip
classif
divers
e
placent
bed
patholog
infarct
case
caus
death
case
e
five
unexplain
sb
accompani
placentamedi
complic
fetal
growth
restrict
fgr
sever
preeclampsia
increas
likelihood
test
posit
antiphospholipid
antibodi
case
sb
addit
clinic
featur
ap
histori
recurr
miscarriag
accompani
placentamedi
complic
caus
death
remain
unexplain
antiphospholipid
antibodi
test
may
consid
perform
import
test
posit
antibodi
least
twice
least
week
interv
sinc
level
antibodi
may
fluctuat
time
may
fals
posit
pregnanc
sever
pregnanc
complic
associ
increas
risk
sb
box
exampl
untreat
intrahepat
cholestasi
pregnanc
icp
estim
sb
risk
howev
studi
women
sb
compar
women
live
birth
report
routin
screen
bile
acid
valu
clinic
featur
suggest
icp
similarli
fetalematern
hemorrhag
fmh
found
sb
case
sever
studi
cohort
women
sb
fmh
report
case
consid
signific
enough
repres
caus
fetal
death
around
case
major
sign
fetal
anemia
placent
examin
andor
autopsi
deliveri
stillborn
babi
may
possibl
affect
result
test
fmh
therefor
advis
immin
test
fmh
diagnosi
sb
gener
pregnanc
complic
mostli
accompani
clinic
matern
andor
fetal
condit
addit
test
guid
base
clinic
present
highincom
countri
sb
caus
infect
wherea
lowand
middleincom
countri
sb
probabl
caus
infect
organ
associ
sb
includ
bacteria
virus
protozoa
spirochet
fungi
infect
initi
chain
event
final
result
pd
sever
mechan
sever
matern
ill
result
system
inflammatori
respons
circulatori
dysfunct
may
caus
fetu
die
indirect
mechan
without
fetal
infect
organ
infect
placenta
caus
placent
damag
result
reduc
fetoplacent
function
exampl
matern
malaria
infect
pregnanc
may
result
placent
malari
involv
character
parasit
leukocyt
intervil
space
accumul
lymphocyt
macrophag
thicken
trophoblast
basement
membran
increas
releas
proinflammatori
cytokin
may
result
abnorm
fetomatern
circul
infecti
organ
may
also
infect
fetu
directli
damag
vital
organ
transplacent
transmit
infect
liver
often
first
organ
infect
sinc
pathogen
enter
fetal
circul
umbil
vein
syphili
haemophilu
influenza
exampl
potenti
transplacent
infect
may
caus
sb
listeria
monocytogen
rare
hematogen
spread
infect
usual
result
placent
involv
microabscess
format
parvoviru
cross
placenta
infect
fetal
erythropoiet
tissu
caus
sever
fetal
anemia
nonimmun
fetal
hydrop
around
infect
case
case
myocard
may
result
sb
infect
earli
pregnanc
caus
congenit
anomali
result
sb
later
stage
pregnanc
exampl
rubella
matern
ascend
genit
tract
infect
result
preterm
labor
caus
intrapartum
sb
earli
neonat
death
ascend
bacteri
infect
fetal
lung
first
infect
inhal
contamin
amniot
fluid
advers
effect
mediat
activ
fetomatern
inflammatori
cascad
global
perspect
infectionrel
stillbirth
repres
major
burden
develop
countri
infectionrel
sb
often
caus
treponema
pallidum
malaria
intrauterin
infect
common
vagin
organ
area
syphili
highli
preval
sb
may
caus
infect
sever
report
sb
caus
epidem
infecti
outbreak
publish
matern
influenza
infect
risk
fetal
death
increas
especi
sever
diseas
outbreak
hepat
e
viru
bangladesh
pregnanc
complic
jaundic
often
result
miscarriag
perinat
mortal
matern
cholera
associ
increas
risk
fetal
death
jordan
outbreak
middl
east
respiratori
syndrom
coronaviru
result
acut
respiratori
ill
sb
brazil
sb
report
associ
zika
viru
result
sever
microcephali
intracrani
calcif
hydrothorax
ascit
fgr
awar
populationbas
health
issu
includ
incid
infecti
diseas
associ
sb
therefor
import
determin
specif
indic
investig
proport
sb
attribut
infect
literatur
relat
extent
investig
carri
classif
system
use
record
caus
death
classif
system
use
strict
criteria
simultan
histopatholog
microbiolog
evid
present
wherea
other
includ
case
base
clinic
sign
without
proven
infect
previou
studi
evalu
diagnost
workup
sb
includ
predominantli
serolog
test
tradit
microbiolog
cultur
placenta
fetu
recent
studi
report
use
molecular
techniqu
polymeras
chain
reaction
pcr
sensit
identifi
specif
viral
bacteri
dna
rna
compar
routin
microbiolog
method
evalu
tissu
sampl
includ
heart
kidney
liver
lung
placenta
case
fetal
death
viral
dna
found
one
tissu
sampl
case
includ
cytomegaloviru
herp
simplex
viru
parvoviru
howev
posit
pcr
assay
alon
necessarili
impli
causal
associ
death
acut
chorioamnion
degre
frequent
occur
sb
case
well
around
liveborn
babi
therefor
chorioamnion
may
repres
contribut
factor
secondari
associ
rather
causal
associ
sb
mani
case
absenc
fetal
inflammatori
respons
emphas
posit
serolog
test
identif
organ
placenta
fetu
prove
causat
therefor
import
perform
autopsi
placent
examin
togeth
serolog
studi
cultur
molecular
test
dnarna
evalu
whether
infecti
agent
like
caus
sb
simpli
confound
contribut
factor
fetal
postmortem
examin
autopsi
tradit
essenti
compon
diagnost
investig
sb
standard
postmortem
protocol
help
evalu
sb
consist
address
pathogenesi
fetal
autopsi
identifi
intrins
underli
dysmorph
abnorm
congenit
anomali
sign
infect
fetal
anaemia
fetal
growth
restrict
elev
brain
liver
ratio
subtl
find
may
determin
caus
sb
absenc
clinic
sign
remain
import
exclud
specif
caus
exampl
one
cohort
sb
case
possibl
probabl
caus
fetal
death
identifi
fetal
autopsi
anoth
cohort
sb
autopsi
consid
valuabl
around
case
howev
numer
compon
postmortem
examin
clinic
review
extern
examin
placent
examin
histolog
evalu
ancillari
test
major
studi
determin
compon
valu
stepwis
analysi
case
probabl
caus
fetal
death
found
perform
clinic
placent
examin
around
case
addit
perform
invas
fetal
autopsi
led
probabl
caus
death
identifi
placent
examin
alon
chang
subsequ
clinic
manag
case
case
medic
recommend
manag
subsequ
pregnanc
chang
base
overal
autopsi
find
anoth
cohort
fetus
includ
miscarriag
week
gestat
sb
neonat
death
prenat
find
confirm
case
addit
find
observ
around
onethird
case
autopsi
led
refin
genet
counsel
risk
recurr
note
despit
full
autopsi
determin
underli
caus
death
remain
subject
mani
case
variat
exist
interpret
clinic
signific
sever
factor
affect
fetu
placenta
well
illustr
effect
classifi
sb
case
differ
classif
system
case
impair
antenat
visual
ultrasound
pregnanc
matern
obes
reduc
amniot
fluid
fetal
autopsi
may
particular
valu
wherea
other
e
exampl
antenat
diagnos
aneuploidi
e
autopsi
examin
add
littl
term
manag
futur
pregnanc
howev
consist
fall
proport
parent
consent
fetal
autopsi
uk
exampl
decreas
find
caus
death
prevent
futur
sb
frequent
mention
reason
parent
consent
autopsi
wherea
emot
distress
prolong
interv
result
import
barrier
consent
reason
failur
offer
perform
fetal
autopsi
lack
knowledg
regard
procedur
discomfort
discuss
death
fetal
autopsi
concern
cost
limit
avail
specialist
servic
clinician
report
workload
neg
public
religion
cultur
issu
import
barrier
one
studi
parent
declin
fetal
autopsi
subsequ
regret
decis
therefor
necessari
explain
famili
potenti
addit
valu
fetal
autopsi
includ
valu
neg
find
futur
discuss
help
parent
decis
fetal
autopsi
necessari
provid
clear
consist
userfriendli
inform
clinician
need
train
improv
knowledg
abil
guid
support
parent
difficult
decis
use
person
sensit
approach
educ
midwiv
obstetrician
increas
knowledg
fetal
autopsi
counsel
senior
staff
regard
procedur
avail
specialist
perinat
pathologist
increas
uptak
perinat
autopsi
possibl
perinat
pathologist
involv
counsel
regard
autopsi
placenta
may
provid
import
inform
regard
event
antenat
period
examin
therefor
play
major
role
investig
sb
depend
classif
system
use
placent
patholog
alloc
causal
sb
seri
reason
placent
function
impair
fetu
depriv
oxygen
nutrient
intrauterin
death
may
occur
placent
process
result
impair
function
may
acut
chronic
chronic
process
evolv
time
gener
recogn
clinic
present
exampl
matern
vascular
malperfus
defect
placent
implant
may
result
matern
hypertens
diseas
fgr
oligohydramnio
reduc
fetal
movement
absenc
time
deliveri
fetal
death
case
addit
specif
histolog
featur
placenta
often
small
low
placent
weight
relat
birth
weight
suggest
independ
risk
factor
sb
studi
placenta
may
demonstr
sign
compens
chronic
hypoxemia
abnorm
blood
flow
increas
syncyti
knot
chorangiosi
fibrin
deposit
chronic
inflamm
process
due
infect
pathogen
microorgan
auto
immun
mechan
may
result
chronic
villiti
fgr
sb
chronic
villiti
observ
frequent
sb
control
versu
five
one
studi
nevertheless
interpret
clinic
signific
individu
case
remain
difficult
risk
factor
earli
pregnanc
marker
chronic
process
beenextens
studi
mani
predict
model
develop
may
aid
identif
fetus
risk
sb
defect
doppler
profil
uterin
arteri
combin
biomark
matern
blood
none
accept
effect
method
identifi
highrisk
pregnanc
sever
acut
placent
process
also
recogn
clinic
patholog
e
exampl
ascend
infect
placent
abrupt
process
occur
rapidli
although
may
superimpos
underli
chronic
process
abrupt
underli
matern
vascular
malperfus
acut
umbil
cord
complic
entangl
compress
occur
postmortem
patholog
confirm
process
difficult
absenc
confirmatori
chang
strictur
florid
underli
parenchym
alter
abnorm
cord
coil
direct
well
pattern
report
associ
sb
sometim
presum
chronic
vascular
obstruct
although
determin
signific
remain
controversi
one
seri
analysi
case
perinat
death
report
almost
case
placent
chang
present
whether
repres
underli
caus
uncertain
case
standard
placent
assess
combin
recod
classif
system
less
like
unexplain
ci
case
placent
examin
contribut
classif
sb
case
placent
examin
provid
sourc
inform
regard
caus
sb
tulip
classif
underli
caus
death
consid
placentarel
almost
one
seri
case
furthermor
placent
patholog
find
vari
accord
gestat
age
death
placent
bed
patholog
suggest
caus
half
sb
occur
week
sharp
declin
week
less
case
term
seri
umbil
cord
complic
suggest
caus
fetal
death
term
case
definit
diagnost
criteria
difficulti
ascertain
variat
studi
consist
issu
appropri
interpret
placent
lesion
present
given
sb
case
caseecontrol
studi
placent
lesion
sb
liveborn
almost
patholog
entiti
present
group
albeit
differ
preval
exampl
fetal
vascular
thrombi
found
case
term
liveborn
term
sb
interpret
complic
fact
definit
infant
consid
truli
healthi
control
extrem
preterm
birth
placent
find
may
prognost
valu
liveborn
infant
use
explan
loss
sb
exampl
liveborn
acceler
matur
report
associ
better
outcom
wherea
fetal
vascular
thrombosi
placent
hypoplasia
associ
advers
outcom
contemporari
practic
assess
placent
patholog
like
move
beyond
macroscop
microscop
assess
structur
abnorm
investig
pathophysiolog
pathway
placenta
contribut
fetal
demis
like
becom
increas
import
genomewid
copi
number
variat
link
clinic
patholog
find
demonstr
specif
copi
number
variat
delet
well
amplif
introduct
widespread
whole
genom
sequenc
along
proteom
metabolom
approach
lead
definit
placent
pathway
involv
fetal
wellb
disturb
may
result
fetal
death
placent
examin
whatev
form
remain
major
import
compon
investig
fetal
death
like
becom
import
introduct
novel
futur
approach
preval
chromosom
abnorm
sb
vari
around
variat
explain
differ
avail
prenat
screen
gestat
fetal
death
includ
studi
cohort
legal
statu
pregnanc
termin
congenit
disord
studi
women
pursu
prenat
diagnosi
chromosom
abnorm
choos
termin
pregnanc
diagnosi
chromosom
anomali
case
signific
proport
fetus
would
die
utero
natur
cours
pregnanc
would
follow
gener
termin
pregnanc
report
sb
statist
subsequ
sb
rate
fall
chromosom
abnorm
pregnanc
termin
molecular
cytogenet
evalu
recommend
standard
practic
sb
dysmorph
featur
structur
malform
center
test
routin
case
sb
dysmporph
featur
subtl
sever
decad
fetal
karyotyp
perform
standard
chromosom
analysi
use
gband
karyotyp
fetal
tissu
obtain
either
amniocentesi
fetal
tissu
collect
post
deliveri
placenta
umbil
cord
closest
placenta
appear
provid
greatest
yield
viabl
tissu
follow
fetal
cartilag
costochondr
junction
patella
howev
sever
limit
describ
use
techniqu
first
sb
may
karyotyp
obtain
due
high
rate
cultur
failur
especi
macer
sb
adequ
viabl
tissu
diminishedlack
second
tradit
techniqu
submicroscop
abnorm
identifi
use
newer
techniqu
eg
molecular
karyotyp
may
therefor
provid
better
result
exampl
use
quantit
fluores
qf
pcr
preval
trisomi
use
microarray
analysi
search
copi
number
variant
genom
segment
includ
caus
delet
duplic
welldescrib
becom
standard
practic
sever
type
microarray
avail
compar
genom
hybrid
array
absolut
quantif
array
singl
nucleotid
probe
qfpcr
microarray
analys
sb
report
superior
diagnost
yield
compar
tradit
karyotyp
versu
mainli
test
case
perform
dna
nonviabl
sometim
even
macer
tissu
case
also
possibl
perform
similar
molecular
karyotyp
formalinfix
paraffinembed
ffpe
tissu
process
fetal
autopsi
sampl
placent
tissu
ffpe
umbil
cord
sampl
allow
addit
diagnost
evalu
later
stage
exampl
histolog
find
indic
need
specif
genet
test
furthermor
microdelet
microdupl
detect
effect
use
microarray
compar
karyotyp
microarray
analysi
superior
detect
chromosom
abnorm
sb
congenit
abnorm
compar
tradit
karyotyp
analysi
versu
one
studi
group
unexplain
sb
genom
widearray
base
profil
placenta
may
result
detect
copi
number
variat
found
cytogenet
method
howev
aetiolog
role
small
genom
imbal
found
case
remain
undetermin
requir
investig
although
like
contribut
small
proport
nonanomal
otherwis
unexplain
sb
balanc
rearrang
lowlevel
mosaic
detect
microarray
analysi
unlik
type
genet
abnorm
signific
contribut
factor
sb
import
emphas
good
genet
counsel
prior
use
microarray
sinc
copi
number
chang
variant
unknown
signific
found
may
lead
increas
parent
anxieti
investig
placenta
may
reveal
placent
mosaic
microarray
analysi
appli
fresh
chorion
villou
samplingbiopsi
presenc
fetoplacent
mosaic
sampl
may
pose
challeng
differenti
cytotrophoblast
mesenchym
tissu
separ
lost
dna
extract
type
confin
placent
mosaic
cpm
cytotrophoblast
appear
associ
spontan
abort
fgr
effect
fetal
develop
type
cpm
mesenchym
unknown
although
cpm
associ
abort
fgr
fetus
cpm
born
aliv
determin
cpm
caus
stillbirth
individu
case
therefor
consid
care
although
molecular
karyotyp
often
perform
nonviabl
tissu
still
worthwhil
tri
obtain
viabl
fetal
tissu
fibroblast
amniocentesi
fibroblast
frozen
need
cultur
order
obtain
fresh
fetal
dna
case
fetal
dna
obtain
noncultur
tissu
insuffici
qualiti
perform
array
fetal
dna
use
array
autopsi
genet
condit
suspect
fetal
dna
good
qualiti
still
avail
mutat
analysi
specif
gene
whole
genom
analysi
imag
techniqu
tradit
use
minor
adjunct
standard
autopsi
decreas
consent
rate
less
invas
techniqu
use
radiolog
evalu
increas
import
applic
techniqu
rapidli
develop
possibl
evalu
sb
may
increas
skelet
radiographi
provid
detail
inform
bone
structur
gener
bone
abnorm
includ
longbon
length
measur
tradit
use
estim
gestat
age
although
much
less
relev
contemporari
practic
due
widespread
implement
antenat
sonographi
date
howev
term
diagnost
valu
one
studi
case
routin
babygram
report
case
potenti
signific
abnorm
identifi
would
miss
select
imag
perform
anoth
cohort
radiograph
sb
abnorm
report
one
case
identifi
caus
death
anoth
studi
case
sb
suggest
plain
radiograph
provid
caus
fetal
death
case
includ
diagnosi
would
otherwis
miss
greater
proport
appar
anomal
radiograph
studi
may
explain
fact
clinic
geneticist
rather
radiologist
perform
evalu
radiograph
may
consequ
select
referr
practic
wherea
skelet
radiograph
often
perform
routin
part
fetal
autopsi
valu
appear
limit
therefor
recommend
standard
like
valu
fetal
skelet
abnorm
suspect
gestat
age
unknown
noninvas
crosssect
imag
pmmri
accept
nearli
parent
contrast
fetal
autopsi
unselect
seri
case
fetal
child
death
sb
valu
pmmri
identif
caus
fetal
death
evalu
minim
invas
autopsi
includ
pmmri
without
percutan
tissu
sampl
identifi
caus
death
major
patholog
lesion
compar
convent
autopsi
case
case
pathologist
radiologist
predict
full
autopsi
unnecessari
concord
rate
caus
death
major
patholog
almost
identifi
cerebralneurolog
abnorm
pmmri
highli
accur
diagnost
techniqu
overal
sensit
specif
even
greater
cerebr
malform
sensit
specif
addit
seri
case
formal
neuropatholog
examin
fetal
autopsi
possibl
due
macer
autolysi
case
pmmri
suppli
diagnost
inform
around
case
howev
limit
appli
particular
pmmri
poor
detect
cerebr
hypox
ischem
injuri
pmmri
valu
detect
cardiac
patholog
overal
sensit
specif
cardiac
patholog
accur
major
structur
heart
diseas
sensit
specif
pmmri
accur
detect
intrathorac
patholog
infect
hemorrhag
overal
sensit
specif
use
detect
anatom
abnorm
pleural
infus
lung
thorac
hypoplasia
pmmri
detect
abdomin
patholog
accur
overal
sensit
specif
especi
good
detect
renal
abnorm
rel
poor
detect
intestin
abnorm
pmmri
accur
exclus
musculoskelet
abnorm
neg
predict
valu
case
pmmr
perform
combin
clinic
examin
skelet
radiograph
skelet
soft
tissu
abnorm
clinic
relev
detect
although
encourag
interpret
pmmri
requir
specialist
expertis
includ
knowledg
normal
postmortem
chang
macer
autolysi
ensur
correct
interpret
cellular
breakdown
chang
fluid
accumul
occur
subcutan
tissu
therefor
provis
adequ
clinic
inform
essenti
pleural
space
pericardi
sac
periton
caviti
fetal
bodi
weight
import
factor
influenc
diagnost
valu
pmmri
highli
like
provid
adequ
diagnost
imag
fetus
bodi
weight
g
protocol
postmortem
imag
specif
sb
need
evalu
local
logist
offer
servic
need
determin
approach
avail
routin
basi
center
parent
consent
complet
fetal
autopsi
fetal
tissu
sampl
requir
minim
invas
autopsi
provid
accept
altern
sinc
parent
may
accept
approach
definit
minim
invas
autopsi
vari
studi
describ
use
postmortem
crosssect
imag
pmmri
combin
form
less
invas
histolog
tissu
sampl
percutan
laparoscop
guid
biopsi
parent
appear
prefer
postmortem
percutan
biopsi
laparoscop
guid
biopsi
extern
noninvas
examin
medic
photograph
whole
bodi
face
hand
feet
suspect
extern
anomali
altern
parent
consent
fetal
autopsi
minim
invas
autopsi
particularli
case
fetal
abnorm
help
clinic
geneticist
suspect
diagnosi
base
dysmorpholog
interpret
subsequ
dna
analysi
sever
techniqu
develop
may
futur
valuabl
sb
evalu
exampl
use
microcomput
tomographi
microct
techniqu
highresolut
evalu
anatom
featur
organ
small
fetus
studi
exvivo
isol
fetal
heart
fetal
heartelung
block
use
microct
provid
highli
accur
threedimension
render
complex
congenit
heart
diseas
evalu
small
earlyag
fetus
highfrequ
postmortem
ultrasound
highfield
pmmri
microct
evalu
diagnost
workup
sb
depend
specif
clinic
featur
per
case
exampl
case
pregnancyinduc
hypertens
placent
abrupt
growthrestrict
stillborn
infant
placent
examin
like
valuabl
test
howev
case
clinic
unsuspect
sb
identifi
late
third
trimest
follow
histori
reduc
fetal
movement
diagnost
yield
lower
potenti
rang
investig
extens
base
current
publish
evid
placent
examin
autopsi
cytogenet
evalu
advis
sb
case
test
fetal
matern
hemorrhag
also
advis
time
diagnosi
unless
caus
death
obviou
eg
massiv
placent
abrupt
case
parent
consent
autopsi
altern
approach
consid
minim
invas
postmortem
examin
pmmri
extern
examin
fetal
pictur
see
fig
parent
inform
diagnost
test
accord
clinic
featur
present
test
result
avail
import
combin
find
clinic
review
investig
death
identifi
probabl
caus
fetal
death
prefer
multidisciplinari
panel
parent
input
without
known
caus
fetal
death
estim
recurr
risk
calcul
develop
evidencebas
protocol
aim
optim
diagnost
workup
sb
accord
specif
clinic
scenario
identif
clinic
circumst
perinat
death
essenti
placent
examin
cytogenet
evalu
fetal
autopsi
investig
fetal
matern
hemorrhag
recommend
perinat
death
parent
consent
autopsi
altern
approach
minim
invas
autopsi
postmortem
mri
good
altern
specif
circumst
routin
test
inherit
thrombophilia
sb
investig
support
evid
test
antiphospholipid
antibodi
may
consid
case
stillbirth
addit
clinic
featur
antiphospholipid
syndrom
accompani
placentamedi
complic
caus
death
remain
unexplain
whole
genom
sequenc
unexplain
stillbirth
could
learn
us
pathophysiolog
stillbirth
exampl
specif
cardio
gene
panel
might
reveal
evid
suggest
caus
arrhythmia
stillbirth
earli
identif
placent
abnorm
utero
identif
women
risk
sb
prevent
intervent
strategi
known
placent
lesion
high
recurr
risk
lymphohistiocyt
villiti
villiti
unknown
etiolog
pravastatin
current
test
may
immunomodul
use
stratif
placent
lesion
intervent
studi
implement
standard
classif
procedur
local
clinic
practic
none
declar
none
